Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2012 by Medical University of South Carolina
Sponsor:
Collaborator:
Michael J. Fox Foundation for Parkinson's Research
Information provided by (Responsible Party):
Vanessa Hinson, Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT01738191
First received: November 28, 2012
Last updated: November 29, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)